Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_assertion type Assertion NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_head.
- NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_assertion wasGeneratedBy ECO_0000203 NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_provenance.
- NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_assertion wasDerivedFrom befree-2016 NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_provenance.
- NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_assertion SIO_000772 17214581 NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_provenance.
- NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_assertion evidence source_evidence_literature NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_provenance.
- NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_assertion description "[Results from phase-II clinical trials with a BLyS antagonist in human SLE and RA have shown the antagonist to have biological and clinical activity along with a favorable safety profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588108.RALeUqBeOLfGLJDaBufPvWBEJVl1veMQLH-EtYeZd8zcQ130_provenance.